Gujarat Fluorochemicals Limited — Q4 FY25 earnings call

Call held 27 May 2025

Management summary

Gujarat Fluorochemicals reported strong Q4 FY25 results with an 8% YoY revenue increase and 28% EBITDA growth, driven by Fluoropolymers. The Battery Materials business is progressing with LFP plant commissioning imminent and significant capex planned. However, the Bulk Chemicals segment faced headwinds due to a plant incident and softening MDC prices, while overall profitability was impacted by higher depreciation and interest costs from capex.

Highlights

  • Revenue from operations of INR 1,225 crores, reflecting an 8% increase year-on-year.

  • EBITDA grew significantly by 28% to INR 305 crores with margins improving from 21% to 25%.

  • Consolidated PAT nearly doubled, reaching INR 191 crores in this quarter.

  • Net debt reduced to INR 1,451 crores from INR 1,769 crores, improving net debt to equity from 0.3% to 0.2%.

  • LFP plant achieved mechanical completion with commissioning and trial production set to begin next month.

Concerns

  • Bulk Chemicals segment underperformed due to an incident at the Dahej CMS-1 plant, leading to approximately 15% production loss.

  • Softening of MDC prices negatively impacted profitability in the Bulk Chemicals segment.

  • Profitability remains impacted by higher depreciation and interest cost associated with capex in the Battery Materials business.

  • Working capital days increased in anticipation of growth, expected to normalize in 1-2 quarters.

Key financials

  1. Revenue from Operations ₹1,225 Cr +8%YoY
  2. EBITDA ₹305 Cr +28%YoY
  3. EBITDA Margin 25%
  4. Consolidated PAT ₹191 Cr
  5. Net Debt ₹1,451 Cr
  6. Net Debt to Equity 20%

What they filed

Q1 FY27: revenue up 10.9%, net profit up 8.6% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,199 1,123 1,158 1,174 1,131 −6%1,026 −9%1,211 +5%1,302 +11%
EBITDA298 307 287 333 360 +21%286 −7%335 +17%365 +10%
Net profit144 153 167 185 195 +35%127 −17%171 +2%201 +9%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Fluoropolymer business
    volume increase in new Fluoropolymers qualitative Revenue Growth Driverstable qualitative Pricessteadily rising qualitative FKM Volumes
  • Fluorochemicals business
    improved qualitative R-22 Pricesimproved qualitative R-125 Sales
  • Specialty Chemicals
    stable qualitative Performancemargin and volume improvements going forward in FY '26 qualitative Outlook
  • Bulk Chemicals segment
    CMS-1 plant incident, ~15% production loss qualitative Challengessoftening qualitative MDC Pricesflat qualitative Caustic Soda Prices
  • Battery Materials business
    stabilized qualitative LiPF6 Productionmechanical completion, trial production next month qualitative LFP Plant Statusadvanced stage of customer validation qualitative Electrolyte & Binder Plants

Capital allocation

high confidence
  • Capex ₹1,600 Cr EV capex will be funded through external fundraise, not relying on GFL's internal cash flow.
    • GFCL EV business (increasing capacities, customer approvals and audits) ₹1,200 Cr
    • GFL (Fluoropolymers and refrigerant business) ₹400 Cr
    • R-32 plant ₹150 Cr
    We have announced capex of INR1,600 crores for FY '26 with INR1,200 crores earmarked for GFCL EV, largely towards increasing the current capacities with increased customer approvals and audits in place and INR400 crores for GFL, largely earmarked for Fluoropolymers and refrigerant business. (Bir Kapoor, Page 5) / The EV businesses, of course, we have indicated earlier, will be funded through external. Whatever had to happen from internal accruals, we already did that. Going forward, we'll be funding it through external fund raise, okay? (Bir Kapoor, Page 8) / Yes, Meet, in fact, in the last quarter call, we had indicated a capex of around INR150 crores, okay? So we are still holding on to that capex, and we'll see how it -- the capacity addition actually takes place with respect to how much we can add in our existing available capacities in the existing plants and how much we'll have to build up the new. But the capex number probably would remain within the number that we have indicated. (Bir Kapoor, Page 14)
  • Debt Net ₹1,451 Cr
    Our net debt as on March 31, 2025 has come down to INR1,451 crores as compared to INR1,769 crores as on March 31, 2024, resulting an improvement of net debt to equity from 0.3% to 0.2%. (Bir Kapoor, Page 3)

Guidance & targets

Profitability

  • Working Capital Normalization Profitability · next 1 to 2 quarters · High confidence normalize
    and we expect this to normalize in next 1 to 2 quarters.

    — Bir Kapoor

Capacity

  • LFP Plant Commissioning Capacity · next month · High confidence begin next month
    Our LFP plant have achieved mechanical completion with commissioning and trial production set to begin next month.

    — Bir Kapoor

  • R-32 Capacity Capacity · High confidence 20,000
    However, the target is 20,000. That's we are holding on to that target.

    — Bir Kapoor

  • Battery Chemicals Commercial Scale Capacity · this year · High confidence commercial scale
    We are reaching a level of maturity where we have all the plants now in this year we'll be at commercial scale.

    — Bir Kapoor

Sales

  • Fluoropolymer Business Growth Sales · FY26 · High confidence almost 25%
    I mean Fluoropolymer, what we are seeing the traction right now, we expect to see almost 25% growth in Fluoropolymers from where we are today.

    — Bir Kapoor

  • R-32 Commercial Sale Sales · second half of this financial year · High confidence commence commercial sale
    expect to commence the commercial sale starting during the second half of this financial year.

    — Bir Kapoor

  • EV Business Revenue Sales · second half of this financial year · Medium confidence trickle in
    We expect the revenue from EV business to trickle in towards the second half of this financial year.

    — Bir Kapoor

  • EV Business Ramp-up Sales · FY '27 · Medium confidence continue and pick up
    But nevertheless, we expect the ramp-up to continue and pick up in FY '27.

    — Bir Kapoor

Cost Savings

  • Power and Fuel Savings Cost Savings · annualized basis · Medium confidence INR120 crores to INR150 crores
    the total saving will be in the tune of INR120 crores to INR150 crores on an annualized basis, but that will trickle in partly this financial year and based on the as and when the facilities comes up.

    — Manoj Agrawal

What to watch in Q1 FY26

Working Capital Normalization

next 1 to 2 quarters
Current Increased working capital days
Target Normalization

Why it matters

Normalization of working capital will improve cash flow and balance sheet efficiency.

and we expect this to normalize in next 1 to 2 quarters.

Risks & concerns

  • Bulk Chemicals Segment Underperformance

    medium

    Incident at Dahej CMS-1 plant led to ~15% production loss and softening MDC prices, negatively impacting profitability.

    Management acknowledged

  • Profitability Impact from Capex-related Depreciation and Interest

    medium

    Higher depreciation and interest costs associated with heavy investments in Battery Materials business are impacting overall profitability.

    Management acknowledged

  • Increased Working Capital Days

    low

    Working capital days increased due to inventory build-up in anticipation of future growth, but expected to normalize in 1-2 quarters.

    Management acknowledged

Q&A highlights

5 direct, 1 evasive
Increased Working Capital and Inventory Build-up Direct
See, in case of Fluoropolymers, we, of course, have our order book, and that's the reason we have increased our supplies and trying to fill up the pipelines. Similarly, in EV battery material as well, we have long-term projected demands given to us by our customers. And in that anticipation, we are building up our pipeline.

Clarifies the rationale behind increased working capital and inventory, indicating demand visibility for key segments.

Asked by Sanjesh Jain

EV Capex Funding and Strategy without Signed Contracts Partial
We already have anticipated demand and the projected demand from our customers and because the capacity building takes a long time, Sanjesh, okay? So when see, the way in fact, I've said it many times that in our EV Material business, we initially started with commercially viable size, okay? And then we are now building up. Once we have demonstrated the capability to produce a high-quality material, which is benchmarked at the world quality. Now we are building up the capacities and adding up the volumes.

Addresses concerns about significant EV capex ahead of formal long-term contracts, emphasizing anticipated demand and the long lead time for capacity building.

Asked by Sanjesh Jain

EV Business Revenue Contribution in FY26 Partial
We expect the revenue from EV business to trickle in towards the second half of this financial year. I would not say sizable because GFL, of course, is a fully grown business. But nevertheless, we expect the ramp-up to continue and pick up in FY '27?

Provides realistic expectations for EV revenue contribution in the near term, indicating a gradual ramp-up rather than immediate significant impact.

Asked by Rohit Nagraj

Impact of Global EV Market Changes on Capex per Ton Direct
However, when we look at our own business plan, we have a very long-term plan and where we have factored in our positioning, which is typically as a supplier, which is an outside China supplier with a very large bouquet of products, providing a robust supply chain, which is independent of China. So our capex's plan, our business model and the projected business financials, we have already accounted for what you see in the market today.

Explains how the company's long-term strategy and positioning as a non-Chinese supplier mitigate the impact of global EV market price changes on their capex benchmarks.

Asked by Naushad Chaudhary

Fluoropolymers Growth Drivers and Market Consolidation Benefits Direct
It's largely from -- Ankur, it's largely from new Fluoropolymers, and that's what we have said because we had built up capacity anticipating the demand to pick up for multiple reasons. And this is exactly the way it is progressing now. It's happening in new Fluoropolymers. ... So some of it has trickled in, but more we see expect to see a lot more because for one of the legacy players stopped their production in a few months back in December only, and they were pipeline.

Clarifies that growth is driven by new, higher value-added Fluoropolymers and confirms benefits from market consolidation are starting to materialize.

Asked by Ankur

LFP Plant Commissioning and Market Focus Direct
There are as I understand, there are no LFP battery manufacturing plant in India as of now. So our focus to begin with, is to market LFP outside India. And we have engaged with multiple customers. And they have also so what we are planning to do is to look at LFP to supply into global markets, okay? Indian market, of course, is also our focus, but it will take some time for Indian markets to come into or demand in India to come into play.

Provides clarity on the LFP plant's market focus, indicating an initial emphasis on global markets rather than immediate Indian demand due to the nascent stage of LFP manufacturing in India.

Asked by Archit

Specific Pricing and Volume Data for Battery Chemicals Evasive
Unfortunately, I'll not be able to share the pricing numbers or the volumes because one of the things that we have indicated earlier that as these capexes as we get commissioned, there will be a certain asset turnover, which gives overall revenue in terms of -- guidance in terms of overall revenue. For individual products to give us a pricing or the volume detail would be difficult as these are sensitive information and also some of them are the competitive confidential information for us.

Highlights the company's reluctance to disclose specific pricing and volume data for competitive reasons, indicating the strategic value and sensitivity of this information.

Asked by Archit

Tax Rate in Q4 FY25 Direct
Sanjesh, this is the one time, sorry, Archit, our tax is lower in this quarter because of onetime credit of reversal of deferred tax liability, which has happened essentially because in the books of accounts, when you -- any asset is there, you have to create a deferred tax liability at the rate of 25%. However, when you do a sound sale of undertaking, it attracts a capital gain tax at the rate of 12.5%. So there is a delta of 25% and 12.5%, which has created a reversal of deferred tax liability to a tune of INR29 crores in this quarter.

Explains the one-time reason for the lower tax rate in Q4 FY25, clarifying it's due to a deferred tax liability reversal related to a sale of undertaking.

Asked by Archit Joshi

2 min read 6 chapters

Detailed narrative

Q4 FY25 Financial Performance Highlights

Gujarat Fluorochemicals delivered a strong Q4 FY25, reporting revenue from operations of INR 1,225 crores, an 8% increase year-on-year. EBITDA saw a significant 28% growth, reaching INR 305 crores, with margins expanding from 21% to 25%. The company's consolidated PAT nearly doubled to INR 191 crores. Furthermore, net debt reduced to INR 1,451 crores as of March 31, 2025, from INR 1,769 crores a year prior, improving the net debt to equity ratio from 0.3% to 0.2%.

Fluoropolymer Segment Driving Growth

The Fluoropolymer business was a key growth driver, with revenue primarily boosted by increased volumes in new, higher value-added Fluoropolymers. Prices in this segment remained stable across domestic and global markets, and FKM volumes are steadily rising due to new project approvals. Management anticipates a robust 25% growth in Fluoropolymers for FY26, benefiting from market consolidation and a focus on high-value grades.

Strategic Investments in EV Battery Materials

The company is making rapid strides in its Battery Materials business, earmarking INR 1,200 crores out of a total INR 1,600 crores capex for FY26 towards GFCL EV. The LiPF6 salt production has stabilized, meeting global specifications, and the LFP plant has achieved mechanical completion, with trial production slated to begin next month. Electrolyte and binder plants are also undergoing advanced customer validation, positioning GFCL EV as a first-mover non-Chinese global supplier.

Bulk Chemicals Challenges and R-32 Outlook

The Bulk Chemicals segment faced challenges in Q4 FY25 due to an incident at the Dahej CMS-1 plant, resulting in approximately 15% production loss. This, combined with softening MDC prices, negatively impacted profitability in the segment. However, the company expects the Bulk Chemicals segment to normalize in coming quarters. In the Fluorochemicals business, R-22 prices improved, and the company is actively working to prepone the commercial sale of R-32 to the second half of FY26, targeting a capacity of 20,000 tons.

Working Capital and Profitability Dynamics

Working capital days increased during the quarter, attributed to building up inventory in anticipation of growth in the coming quarters, which management expects to normalize within 1-2 quarters. While the Battery Materials business is a key growth area, its profitability is currently impacted by higher depreciation and interest costs associated with the ongoing capex. These costs are expected to normalize as revenues from the new segments ramp up.

EV Market Strategy and Funding Approach

GFCL EV's strategy focuses on the US and Indian markets, aiming to be a key global supplier with a wide range of products. Despite some reported delays in the global battery materials market, the company's long-term plan and capex benchmarks remain consistent for outside-China markets. The INR 1,200 crores capex for the EV business in FY26 will be funded through external fundraises, ensuring GFL's internal cash flow is not relied upon for these investments.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls